Our Conversations Webinar Series is an opportunity to link national experts in colorectal cancer and other related fields to you, right in the comfort of your own home. The programs are designed to empower you to play a leading role in your healthcare management.
On July 15, we hosted “Is SIR-Spheres Microspheres Targeted Radiation an Option for Me?”, which provided an overview of SIR-Spheres microspheres targeted radiation therapy, as well as a review of the findings of the recent SIRFLOX study presented at the American Society of Clinical Oncology (ASCO) Annual Meeting. The SIRFLOX study was the first large study to examine the delay in regrowth of liver tumors when selective internal radiation therapy is combined with chemotherapy.
Did you miss the webinar? You're in luck—here are the top takeaways and the replay:
- Surgery is the best treatment with liver tumors, but when that is not possible other treatments are considered and are important because the liver is the most important organ to keep healthy.
- SIR-Spheres Y-90 Resin microspheres are a liver directed therapy with a unique mode of action and can be used by themselves or in combination with chemo to improve patient outcomes.
- There are many published and individual case studies with SIR-Spheres Y-90 Resin microspheres supporting good outcomes across all lines of therapy, and the treatment is associated with a favorable safety profile.
- Recent first-line data at ASCO showed that when SIR-Spheres Y-90 Resin microspheres were combined with chemo, there was an eight month improvement in time until the liver tumors progressed over chemo alone.
- SIR-Spheres Y-90 Resin microspheres is one strategy for patients with non-resectable metastases that are mainly limited to the liver.
Thank you to our webinar partner Sirtex for their generous support.
Be sure to download the slides. Don’t forget, the Colon Cancer Alliance serves as a source of information about colon health. If you have additional questions about colon cancer screening or are in need of support, please contact our free Helpline at (877) 422-2030. We’re here to help.